Clinical trials
Phase 2/3 Colitis, Ulcerative trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 9 |
| Recruiting | 5 |
| Unknown status | 5 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Facet Biotech | 3 |
| Janssen Research & Development, LLC | 3 |
| AbbVie | 2 |
| Theravance Biopharma | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Assiut University | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Fakultas Kedokteran Universitas Indonesia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 34 |
| Inflammatory Bowel Diseases | 7 |
| Colitis | 3 |
| Crohn Disease | 3 |
| Colonic Diseases | 1 |
| Digestive System Diseases | 1 |
| Dysbiosis | 1 |
| Fatigue | 1 |
| Gastrointestinal Diseases | 1 |
| Intestinal Diseases | 1 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.